djledda.de main
Vous ne pouvez pas sélectionner plus de 25 sujets Les noms de sujets doivent commencer par une lettre ou un nombre, peuvent contenir des tirets ('-') et peuvent comporter jusqu'à 35 caractères.
 
 

733 lignes
46 KiB

  1. <html>
  2. <head><title>Lactate vs. CO2 in wounds, sickness, and aging; the other approach to cancer</title></head>
  3. <body>
  4. <h1>
  5. Lactate vs. CO2 in wounds, sickness, and aging; the other approach to cancer
  6. </h1>
  7. <p>
  8. <hr />
  9. <hr />
  10. <hr />
  11. </p>
  12. <p>
  13. <strong>
  14. GLOSSARY</strong>
  15. </p>
  16. <p>
  17. <strong>Aerobic glycolysis,</strong> the conversion of glucose to lactic acid even in the presence of
  18. oxygen. The presence of oxygen normally restrains glycolysis so that glucose is converted to carbon dioxide
  19. instead of lactic acid.
  20. </p>
  21. <p>
  22. <strong>Anaerobic glycolysis,</strong> the increased conversion of glucose to lactic acid when the supply of
  23. oxygen isn't sufficient, which is a normal event during intense muscle action.
  24. </p>
  25. <p>
  26. <strong>"Warburg Effect"</strong> refers to Otto Warburg's observation that cancer cells produce lactic acid
  27. even in the presence of adequate oxygen. Cancer cells don't "live on glucose," since they are highly adapted
  28. to survive on protein and fats.
  29. </p>
  30. <p>
  31. <strong>Pasteur Effect,</strong> the normal response of cells to restrain glycolysis in the presence of
  32. adequate oxygen.
  33. </p>
  34. <p>
  35. <strong>Crabtree Effect,</strong> observed originally in yeast, refers to the inhibition of respiration in
  36. the presence of glucose. This occurs in cancers (e.g., Miralpeix, et al., 1990) and in rapidly proliferating
  37. normal cells (e.g., Guppy, et al., 1993).
  38. </p>
  39. <p>
  40. <strong>"Cancer metabolism"</strong> or stress metabolism typically involves an excess of the adaptive
  41. hormones, resulting from an imbalance of the demands made on the organism and the resources available to the
  42. organism. Excessive stimulation depletes glucose and produces lactic acid, and causes cortisol to increase,
  43. causing a shift to the consumption of fat and protein rather than glucose. Increased cortisol activates the
  44. Randle effect (the inhibition of glucose oxidation by free fatty acids), accelerates the breakdown of
  45. protein into amino acids, and activates the enzyme fatty acid synthase, which produces fatty acids from
  46. amino acids and pyruvate, to be oxidized in a "futile cycle," producing heat, and increasing the liberation
  47. of ammonia from the amino acids. Ammonia suppresses respiratory, and stimulates glycolytic, activity.
  48. </p>
  49. <p>
  50. <hr />
  51. <hr />
  52. <hr />
  53. </p>
  54. <p>
  55. The presence of lactic acid in our tissues is very meaningful, but it is normally treated as only an
  56. indicator, rather than as a cause, of biological problems. Its presence in rosacea, arthritis, heart
  57. disease, diabetes, neurological diseases and cancer has been recognized, and recently it is being recognized
  58. that suppressing it can be curative, after fifty years of denial.
  59. </p>
  60. <p>
  61. The influence of politics on science is so profound that neither historians nor scientists often care to
  62. consider it honestly and in depth.
  63. </p>
  64. <p>
  65. From the 19th century until the second quarter of the 20th century, cancer was investigated mainly as a
  66. metabolic problem. This work, understanding the basic chemistry of metabolism, was culminating in the 1920s
  67. in the work of Otto Warburg and Albert Szent-Gyorgyi on respiration. Warburg demonstrated as early as 1920
  68. that a respiratory defect, causing aerobic glycolysis, i.e., the production of lactic acid even in the
  69. presence of oxygen, was an essential feature of cancer. (The formation of lactic acid is normal and adaptive
  70. when the supply of oxygen isn't adequate to meet energy demands, for example when running.)
  71. </p>
  72. <p>
  73. Many people recognized that this was likely to be the key to the "cancer problem." But in the US, several
  74. factors came together to block this line of investigation.
  75. </p>
  76. <p>
  77. The world wars contributed to the isolation of German scientists, and Warburg, of the famous Jewish banking
  78. family, continued his work in Germany with the support of the government, despite his open opposition to
  79. Nazism. In the years after the war, nothing positive could be said in the US about his work on cancer.
  80. </p>
  81. <p>
  82. The metabolic interpretation of disease that had been making progress for several decades was suddenly
  83. submerged when government research financing began concentrating on genetic and viral interpretations of
  84. disease.
  85. </p>
  86. <p>
  87. If an apparently non-infectious disease couldn't be explained on the basis of an inherited
  88. tendency---insanity, epilepsy, diabetes, toxemia of pregnancy, and cancer, for example---then genetic
  89. changes occurring in the individual, as a result of chance or a virus, were invoked. Nutrition and other
  90. conditions of life were until fairly recently said to have no influence on health if the person consumed
  91. sufficient calories and a minimum amount of the essential vitamins, minerals, and protein. The cult of
  92. genetic determinism was so powerful that it wasn't affected by the facts.
  93. </p>
  94. <p>
  95. In 1932, a pediatrician, Alexis Hartmann (with M. Senn) in St. Louis, injected intravenously a solution of
  96. sodium lactate into patients with metabolic acidosis, and several of them survived---despite the fact that
  97. some of them were already suffering from an excess of lactate. The subsequent widespread use of lactate
  98. solutions in hospitals has contributed to the general denial of its toxicity.
  99. </p>
  100. <p>
  101. Hartmann and Senn used racemic lactate, that is, a mixture of D-lactate and L-lactate. Our own tissues
  102. produce mostly L-lactate, but they can produce small amounts of D-lactate; larger amounts are produced by
  103. diabetics. Intestinal bacteria can produce large amounts of it, and it has many toxic effects. Methylglyoxal
  104. can be formed from either form of lactate, and it is an important factor in the glycation of proteins. It
  105. can also be formed from MDA, a product of lipid peroxidation. Protein glycation is an important factor in
  106. diabetes and aging, but glucose, rather than lactate and polyunsaturated fats, is commonly said to be the
  107. cause.
  108. </p>
  109. <p>
  110. About 50 years ago, lactate was known to induce the formation of new blood vessels, and for a much longer
  111. time it has been known to cause vasodilation and edema. In 1968, it was shown to stimulate collagen
  112. synthesis.
  113. </p>
  114. <p>
  115. Normally, collagen synthesis and neovascularization are caused by lack of oxygen, but lactate can cause them
  116. to occur even in the presence of oxygen. Maintenance of a normal extracellular matrix is essential for
  117. normal functioning and cellular differentiation. Abnormally stimulated collagen synthesis probably
  118. accelerates tumor growth (Rajkumar, et al., 2006).
  119. </p>
  120. <p>
  121. Nervous and hormonal factors can cause lactate to accumulate, even without prior damage to the mitochondria
  122. (e.g., B. Levy, et al., 2003). Psychological, as well as physical, stress and overactivation of glutamate
  123. receptors can cause harmful accumulation of lactate in the brain (Uehara, et al., 2005). Rather than just
  124. being "associated with" tissue damage, lactate directly contributes to the damage, for example in the brain,
  125. causing nerve cell loss by increasing the release of excitotoxic glutamate (Xiang, et al, 2004). When a
  126. panic reaction is produced by sodium lactate, the reduction of protective neurosteroids appears to
  127. contribute to the excitatory state (Eser, et al. 2006); this would make the brain more susceptible to
  128. damage.
  129. </p>
  130. <p>
  131. Lactate increases blood viscosity, mimics stress, causes inflammation, and contributes to shock. Lactated
  132. Ringer's solution contributes to the tissue damage caused by shock, when it's used to resuscitate shock
  133. victims (Deree, et al., 2007, 2008): it contributes to the inflammatory processes associated with shock,
  134. unlike the use of hypertonic saline and other solutions. Lactate contributes to diabetes, inhibiting the
  135. ability to oxidize glucose. It promotes endothelial cell migration and leakiness, with increased vascular
  136. permeability factor (VPF or vascular endothelial growth factor, VEGF) (Nagy, et al. 1985): this can lead to
  137. breakdown of the "blood-brain barrier."
  138. </p>
  139. <p>
  140. In the brain, lactate can cause nerve damage, increasing intracellular fat accumulation, chromatin clumping,
  141. and mitochondrial swelling (Norenberg, et al., 1987).
  142. </p>
  143. <p>
  144. The lactate in peritoneal dialysis solution impairs differentiation and maturation of (immune, monocyte
  145. derived) dendritic cells; according to the authors of the study, "These findings have important implications
  146. for the initiation of immune responses under high lactate conditions, such as those occurring within tumor
  147. tissues or after macrophage activation<strong>" </strong>
  148. (Puig-Kr"ger, et al., 2003).<strong> </strong>
  149. </p>
  150. <p>
  151. Lactate also causes macrophages and synovial fibroblasts to release PGE2, which can contribute to
  152. inflammation and bone resorption (Dawes and Rushton, 1994). This is the prostaglandin known to activate the
  153. formation of estrogen (Haffty, et al., 2008).
  154. </p>
  155. <p>
  156. Hartmann's lactated solution has been widely used in hospitals for resuscitation and for patients after
  157. heart surgery and other stressful procedures, but until recently only a few people have objected to its use,
  158. and most of the objection has been to the use of racemic lactate, rather than to lactate itself. In recent
  159. years several studies have compared hypertonic saline (lacking the minerals considered essential since
  160. Sydney Ringer formulated his solution around 1885), and have found it in some cases superior to the
  161. "balanced" lactate solution. Even hypertonic glucose, without minerals, has produced good results in some
  162. studies.
  163. </p>
  164. <p>
  165. A solution containing a large amount of lactate has been used for peritoneal dialysis when there is kidney
  166. failure, but several studies have compared solutions using bicarbonate instead of lactate, and found that
  167. they don't cause the severe damage that always happened with the traditional solution.
  168. </p>
  169. <p>
  170. While Warburg was investigating the roles of glycolysis and respiration in cancer,<strong> </strong>a
  171. physician with a background in chemistry, W.F. Koch, in Detroit, was showing that the ability to use oxygen
  172. made the difference between health and sickness, and that the cancer metabolism could be corrected by
  173. restoring the efficient use of oxygen. He argued that a respiratory defect was responsible for
  174. immunodeficiency, allergy, and defective function of muscles, nerves, and secretory cells, as well as
  175. cancer. Koch's idea of cancer's metabolic cause and its curability directly challenged the doctrine of the
  176. genetic irreversibility of cancer that was central to governmental and commercial medical commitments.
  177. </p>
  178. <p>
  179. Albert Szent-Gyorgyi respected Koch's work, and spent years investigating the involvement of the lactate
  180. metabolites, methylgyoxal and glyoxal, in cell physiology, but since the government's campaign against Koch
  181. was still active when Szent-Gyorgyi came to the U.S., he worked out many of the implications of Koch's work
  182. relating to cellular oxidation without mentioning his name.
  183. </p>
  184. <p>
  185. Lactate formation from glucose is increased when anything interferes with respiratory energy production, but
  186. lactate, through a variety of mechanisms, can itself suppress cellular respiration. (This has been called
  187. the Crabtree effect.) Lactate can also inhibit its own formation, slowing glycolysis. In the healthy cell,
  188. the mitochondrion keeps glycolysis working by consuming pyruvate and electrons (or "hydrogens") from NADH,
  189. keeping the cell highly oxidized, with a ratio of NAD+/NADH of about 200. When the mitochondrion's ability
  190. to consume pyruvate and NADH is limited, the pyruvate itself accepts the hydrogen from NADH, forming lactic
  191. acid and NAD+ in the process. As long as lactate leaves the cell as fast as it forms, glycolysis will
  192. provide ATP to allow the cell to survive. Oxygen and pyruvate are normally "electron sinks," regenerating
  193. the NAD+ needed to produce energy from glucose.
  194. </p>
  195. <p>
  196. But if too much lactate is present, slowing glycolytic production of ATP, the cell with defective
  197. respiration will die unless an alternative electron sink is available. The synthesis of fatty acids is such
  198. a sink, if electrons (hydrogens) can be transferred from NADH to NADP+, forming NADPH, which is the reducing
  199. substance required for turning carbohydrates and pyruvate and amino acids into fats.
  200. </p>
  201. <p>
  202. This transfer can be activated by the transhydrogenase enzymes in the mitochondria, and also by interactions
  203. of some dehydrogenase enzymes.
  204. </p>
  205. <p>
  206. The enzyme, fatty acid synthase (FAS), normally active in the liver and fat cells and in the
  207. estrogen-stimulated uterus, is highly active in cancers, and its activity is an inverse indicator of
  208. prognosis. Inhibiting it can cause cancer cells to die, so the pharmaceutical industry is looking for drugs
  209. that can safely inhibit it. This enzyme is closely associated with the rate of cell proliferation, and its
  210. activity is increased by both cortisol and estrogen.
  211. </p>
  212. <p>
  213. The first biochemical event when a cell responds to estrogen is the synthesis of fat. Estrogen can activate
  214. transhydrogenases, and early studies of estrogen's biological effects provided considerable evidence that
  215. its actions were the result of the steroid molecule's direct participation in hydrogen transfers, oxidations
  216. and reductions. E.V. Jensen's claim that estrogen acts only through a "receptor protein" which activated
  217. gene transcription was based on his experimental evidence indicating that estrogen doesn't participate in
  218. oxidation and reduction processes in the uterus, but subsequently his claim has turned out to be false.
  219. </p>
  220. <p>
  221. Glycolysis is very inefficient for producing usable energy compared to the respiratory metabolism of the
  222. mitochondria, and when lactate is carried to the liver, its conversion to glucose adds to the energy drain
  223. on the organism.
  224. </p>
  225. <p>
  226. The hypoglycemia and related events resulting from accelerated glycolysis provide a stimulus for increased
  227. activity of the adaptive hormones, including cortisol. Cortisol helps to maintain blood sugar by increasing
  228. the conversion of protein to amino acids, and mobilizing free fatty acids from fat stores. The free fatty
  229. acids inhibit the use of glucose, so the stress metabolism relies largely on the consumption of amino acids.
  230. This increases the formation of ammonia, yet the combination of glycolysis and fat oxidation provides less
  231. carbon dioxide, which is needed for the conversion of ammonia to urea. Ammonia stimulates the formation of
  232. lactate, while carbon dioxide inhibits it.
  233. </p>
  234. <p>
  235. Starving an animal with a tumor increases the stress hormones, providing free fatty acids and amino acids,
  236. and accelerates the tumor's growth (Sauer and Dauchy, 1987); it's impossible to "starve a tumor," by the
  237. methods often used. Preventing the excessive breakdown of protein and reducing the release of fatty acids
  238. from fat cells would probably cause many cancer cells to die, despite the availability of glucose, because
  239. of lactate's toxic effects, combined with the energy deficit caused by the respiratory defect that causes
  240. their aerobic glycolysis. Recently, the intrinsically high rate of cell death in tumors has been recognized.
  241. The tumor is maintained and enlarged by the recruitment of "stem cells." These cells normally would repair
  242. or regenerate the tissue, but under the existing metabolic conditions, they fail to differentiate properly.
  243. </p>
  244. <p>
  245. The extracellular matrix in the tumor is abnormal, as well as the metabolites and signal substances being
  246. produced there, and the new cells fail to receive the instructions needed to restore the normal functions to
  247. the damaged tissue. These abnormal conditions can cause abnormal differentiation, and this cellular state is
  248. likely to involve chemical modification of proteins, including remodeling of the chromosomes through
  249. acetylation of the histones (Alam, et al., 2008; Suuronen, et al., 2006). The protein-protective effects of
  250. carbon dioxide are replaced by the protein-damaging effects of lactate and its metabolites.
  251. </p>
  252. <p>
  253. The ability of lactic acid to displace carbon dioxide is probably involved in its effects on the blood
  254. clotting system. It contributes to disseminated intravascular coagulation and consumption coagulopathy, and
  255. increases the tendency of red cells to aggregate, forming "blood sludge," and makes red cells more rigid,
  256. increasing the viscosity of blood and impairing circulation in the small vessels. (Schmid-Sch"nbein, 1981;
  257. Kobayashi, et al., 2001; Martin, et al., 2002; Yamazaki, et al., 2006.)
  258. </p>
  259. <p>
  260. The features of the stress metabolism include increases of stress hormones, lactate, ammonia, free fatty
  261. acids, and fat synthesis, and a decrease in carbon dioxide. Factors that lower the stress hormones, increase
  262. carbon dioxide, and help to lower the circulating free fatty acids, lactate, and ammonia, include vitamin B1
  263. (to increase CO2 and reduce lactate), niacinamide (to reduce free fatty acids), sugar (to reduce cortisol,
  264. adrenaline, and free fatty acids), salt (to lower adrenaline), thyroid hormone (to increase CO2). Vitamins
  265. D, K, B6 and biotin are also closely involved with carbon dioxide metabolism. Biotin deficiency can cause
  266. aerobic glycolysis with increased fat synthesis (Marshall, et al., 1976).
  267. </p>
  268. <p>
  269. A protein deficiency, possibly by increasing cortisol, is likely to contribute to increased FAS and fat
  270. synthesis (Bannister, et al., 1983), but the dietary protein shouldn't provide an excess of tryptophan,
  271. because of tryptophan's role as serotonin precursor--serotonin increases inflammation and glycolysis
  272. (Koren-Schwartzer, et al., 1994).
  273. </p>
  274. <p>
  275. Incidental stresses, such as strenuous exercise combined with fasting (e.g., running or working before
  276. eating breakfast) not only directly trigger the production of lactate and ammonia, they also are likely to
  277. increase the absorption of bacterial endotoxin from the intestine. Endotoxin is a ubiquitous and chronic
  278. stressor. It increases lactate and nitric oxide, poisoning mitochondrial respiration, precipitating the
  279. secretion of the adaptive stress hormones, which don't always fully repair the cellular damage.
  280. </p>
  281. <p>
  282. Aspirin protects cells in many ways, interrupting excitotoxic processes by blocking nitric oxide and
  283. prostaglandins, and consequently it inhibits cell proliferation, and in some cases inhibits glycolysis, but
  284. the fact that it can inhibit FAS (Beynen, et al., 1982) is very important in understanding its role in
  285. cancer.
  286. </p>
  287. <p>
  288. There are several specific signals produced by lactate that can promote growth and other features of cancer,
  289. and it happens that aspirin antagonizes those: HIF, NF-kappaB, the kinase cascades, cyclin D1, and heme
  290. oxygenase.
  291. </p>
  292. <p>
  293. Lactate and inflammation promote each other in a vicious cycle (Kawauchi, et al., 2008).
  294. </p>
  295. <p>
  296. The toxic mechanism of bacterial endotoxin (lipopolysaccharide) involves inappropriate stimulation (Wang and
  297. White, 1999) of cells, followed by inflammation and mitochondrial inhibition. The stimulation seems to be a
  298. direct "biophysical" action on cells, causing them to take up water (Minutoli, et al., 2008), which is
  299. especially interesting, since estrogen's immediate excitatory effect causes cells to take up water.
  300. </p>
  301. <p>
  302. Hypoosmolarity itself is excitatory and anabolic. It stimulates lipolysis and fat oxidation (Keller, et al.
  303. 2003), and osmotic swelling stimulates glycolysis and inhibits mitochondrial respiration (Levko, et al.,
  304. 2000). Endotoxin causes hyponatremia (Tyler, et al., 1994), and a hypertonic salt solution is protective,
  305. lactate solutions are harmful. Other stresses and inflammations also cause hyponatremia.
  306. </p>
  307. <p>
  308. One of the effects of endotoxin that leads to prolonged cellular excitation is its inhibition of the
  309. glucuronidation system (B"nhegyi, et al., 1995), since this inhibition allows excitatory estrogen to
  310. accumulate.
  311. </p>
  312. <p>
  313. In women and rats, antibiotics were found to cause blood levels of estrogen and cortisol to decrease, while
  314. progesterone increased. This effect apparently resulted from the liver's increased ability to inactivate
  315. estrogen and to maintain blood sugar when the endotoxin stress was decreased.
  316. </p>
  317. <p>
  318. Now that hog farmers' use of antibiotics to stimulate growth has been discouraged, they have sought
  319. vegetables that have a natural antibiotic effect, reducing the formation and absorption of the intestinal
  320. toxins. The human diet can be similarly adjusted, to minimize the production and absorption of the bacterial
  321. toxins.
  322. </p>
  323. <p>
  324. In 2007, two Canadian researchers announced that they were investigating the drug dichloroacetate, which
  325. blocks glycolysis, stopping the production of lactic acid, as a cancer treatment, with success. The drug
  326. (dichloroacetate) has toxic side effects, but it is useful in several other conditions involving
  327. over-production of lactic acid. Other drugs that inhibit glycolysis have also shown anticancer effects in
  328. animals, but are in themselves very toxic. On the theoretical level, it would be better to inhibit only
  329. aerobic glycolysis, rather than inhibiting enzymes that are essential for all glycolysis.
  330. </p>
  331. <p>
  332. Since endotoxemia can produce aerobic glycolysis in an otherwise healthy person (Bundgaard, et al., 2003), a
  333. minimally "Warburgian" approach--i.e,, a merely reasonable approach--would involve minimizing the absorption
  334. of endotoxin. Inhibiting bacterial growth, while optimizing intestinal resistance, would have no harmful
  335. side effects. Preventing excessive sympathetic nervous activity and maintaining the intestine's energy
  336. production can be achieved by optimizing hormones and nutrition. Something as simple as a grated carrot with
  337. salt and vinegar can produce major changes in bowel health, reducing endotoxin absorption, and restoring
  338. constructive hormonal functions.
  339. </p>
  340. <p>
  341. Medical tradition and inertia make it unlikely that the connection between cancer and bowel toxins will be
  342. recognized by the mainstream of medicine and governemt. In another article I will describe some of the
  343. recent history relating to this issue.
  344. </p>
  345. <p>
  346. It's nice that some cancer researchers are now remembering Warburg, but unfortunately they are usually just
  347. fitting the fact of cancer's aerobic glycolysis into the genetic mutant cell paradigm, thinking of the
  348. respiratory defect as just another opportunity for killing the evil deviant cancer cell, rather than looking
  349. for the causes of the respiratory defect. Warburg, Koch, and Szent-Gyorgyi had a comprehensive view of
  350. biology, in which the aerobic production of lactate, resulting from a respiratory defect, itself was
  351. functonally related to the nature of cancer.
  352. </p>
  353. <p>
  354. A focus on correcting the respiratory defect would be relevant for all of the diseases and conditions
  355. (including heart disease, diabetes, dementia) involving inflammation and inappropriate excitation, not just
  356. for cancer.
  357. </p>
  358. <p><h3>REFERENCES</h3></p>
  359. <p>
  360. Resuscitation. 2008 Feb;76(2):299-310. <strong>Impact of resuscitation strategies on the acetylation status
  361. of cardiac histones in a swine model of hemorrhage.</strong>
  362. Alam HB, Shults C, Ahuja N, Ayuste EC, Chen H, Koustova E, Sailhamer EA, Li Y, Liu B, de Moya M, Velmahos
  363. GC.
  364. </p>
  365. <p>
  366. Mol Genet Metab 1998 Mar;63(3):235-8. <strong>Activation of membrane skeleton-bound phosphofructokinase in
  367. erythrocytes induced by serotonin.</strong> Assouline-Cohen M, Ben-Porat H, Beitner R. We show here that
  368. serotonin, both in vivo and in vitro, induced a marked activation of phosphofructokinase, the rate-limiting
  369. enzyme in glycolysis, in the membrane-skeleton fraction from erythrocytes. Concomitantly, the hormone
  370. induced a striking increase in lactate content, reflecting stimulation of glycolysis. The enzyme's activity
  371. in the cytosolic (soluble) fraction remained unchanged. These results suggest a defense mechanism in the
  372. erythrocytes against the damaging effects of serotonin, whose concentration in plasma increases in many
  373. diseases and is implicated as playing an important role in circulation disturbances.
  374. </p>
  375. <p>
  376. Biochem Pharmacol. 1995 Jan 6;49(1):65-8.<strong>
  377. Endotoxin inhibits glucuronidation in the liver. An effect mediated by intercellular
  378. communication.</strong>
  379. B"nhegyi G, Mucha I, Garz" T, Antoni F, Mandl J.
  380. </p>
  381. <p>
  382. Br J Nutr. 1983 Sep;50(2):291-302. <strong>The effect of biotin deficiency and dietary protein content on
  383. lipogenesis, gluconeogenesis and related enzyme activities in chick liver.</strong> Bannister DW,
  384. O'Neill IE, Whitehead CC.
  385. </p>
  386. <p>
  387. J Cell Biochem. 2004 Jan 1;91(1):47-53.<strong>
  388. Fatty acid synthase: a metabolic oncogene in prostate cancer?</strong> Baron A, Migita T, Tang D, Loda
  389. M.
  390. </p>
  391. <p>
  392. Neurol Res. 2008 Mar;30(2):160-9. <strong>Skeletal muscle is enriched in hematopoietic stem cells and not
  393. inflammatory cells in cachectic mice.</strong> Berardi E, Aulino P, Murfuni I, Toschi A, Padula F,
  394. Scicchitano BM, Coletti D, Adamo S.
  395. </p>
  396. <p>
  397. Scand J Clin Lab Invest 1977 May;37(3):235-41. <strong>Effects of different doses of acetylsalicylic acid on
  398. renal oxygen consumption.</strong> Berg KJ, Bergan A
  399. </p>
  400. <p>
  401. Toxicology. 1982;24(1):33-43. <strong>Inhibition of hepatic lipogenesis by salicylate.</strong>
  402. Beynen AC, Buechler KF, van der Molen AJ, Geelen MJ.
  403. </p>
  404. <p>
  405. Am J Physiol Heart Circ Physiol. 2003 Mar;284(3):H1028-34. Epub 2002 Nov 21. <strong>Endotoxemia stimulates
  406. skeletal muscle Na+-K+-ATPase and raises blood lactate under aerobic conditions in humans.</strong>
  407. Bundgaard H, Kjeldsen K, Suarez Krabbe K, van Hall G, Simonsen L, Qvist J, Hansen CM, Moller K, Fonsmark L,
  408. Lav Madsen P, Klarlund Pedersen B.
  409. </p>
  410. <p>
  411. J Natl Cancer Inst. 1967 Jun;38(6):839-63.<strong>
  412. On the significance of glucolysis for cancer growth, with special reference to Morris rat
  413. hepatomas.</strong>
  414. Burk D, Woods M, Hunter J.
  415. </p>
  416. <p>
  417. Arch Geschwulstforsch. 1967;28(4):305-19. <strong>Newer aspects of glucose fermentation in cancer growth and
  418. control.</strong> Burk D, Woods M.
  419. </p>
  420. <p>
  421. Eur J Pharmacol. 2005 Jul 11;517(3):158-64. <strong>Aspirin inhibits NF-kappaB activation in a
  422. glycolysis-depleted lung epithelial cell line.</strong> Cuesta E, Boada J, Perales JC, Roig T, Bermudez
  423. J.
  424. </p>
  425. <p>
  426. Clin Mater. 1994;17(4):157-63. <strong>The effects of lactic acid on PGE2 production by macrophages and
  427. human synovial fibroblasts: a possible explanation for problems associated with the degradation of
  428. poly(lactide) implants?</strong>
  429. Dawes E, Rushton N.
  430. </p>
  431. <p>
  432. J Surg Res. 2007 Nov;143(1):99-108.<strong>
  433. Pentoxifylline attenuates lung injury and modulates transcription factor activity in hemorrhagic
  434. shock.</strong>
  435. Deree J, Martins J, de Campos T, Putnam JG, Loomis WH, Wolf P, Coimbra R.
  436. </p>
  437. <p>
  438. J Trauma. 2007 Apr;62(4):818-27; discussion 827-8. <strong>Hypertonic saline and pentoxifylline attenuates
  439. gut injury after hemorrhagic shock: the kinder, gentler resuscitation.</strong> Deree J, de Campos T,
  440. Shenvi E, Loomis WH, Hoyt DB, Coimbra R.
  441. </p>
  442. <p>
  443. J Trauma. 2007 Jan;62(1):104-11. <strong>Hypertonic saline and pentoxifylline reduces hemorrhagic shock
  444. resuscitation-induced pulmonary inflammation through attenuation of neutrophil degranulation and
  445. proinflammatory mediator synthesis.</strong> Deree J, Martins JO, Leedom A, Lamon B, Putnam J, de Campos
  446. T, Hoyt DB, Wolf P, Coimbra R.
  447. </p>
  448. <p>
  449. J Trauma. 2008 May;64(5):1230-8; discussion 1238-9.<strong>
  450. Hepatic transcription factor activation and proinflammatory mediator production is attenuated by
  451. hypertonic saline and pentoxifylline resuscitation after hemorrhagic shock.</strong> Deree J, Loomis WH,
  452. Wolf P, <strong>Coimbra R</strong>.
  453. </p>
  454. <p>
  455. Neuroscience. 2006;138(3):1041-8. <strong>Neuroactive steroids as modulators of depression and
  456. anxiety.</strong> Eser D, Romeo E, Baghai TC, di Michele F, Sch"le C, Pasini A, Zwanzger P, Padberg F,
  457. Rupprecht R.
  458. </p>
  459. <p>
  460. Cancer Res. 2003 Jul 15;63(14):3847-54. <strong>The glycolytic phenotype in carcinogenesis and tumor
  461. invasion: insights through mathematical models.</strong> Gatenby RA, Gawlinski ET.
  462. </p>
  463. <p>
  464. J Bioenerg Biomembr. 2007 Jun;39(3):251-7. <strong>Adaptive landscapes and emergent phenotypes: why do
  465. cancers have high glycolysis?</strong> Gillies RJ, Gatenby RA.
  466. </p>
  467. <p>
  468. Biochem J. 2002 May 15;364(Pt 1):309-15. <strong>Contribution by different fuels and metabolic pathways to
  469. the total ATP turnover of proliferating MCF-7 breast cancer cells.</strong> Guppy M, Leedman P, Zu X,
  470. Russell V.
  471. </p>
  472. <p>
  473. Surg Forum. 1958;9:614-9.<strong>
  474. An estradiol sensitive transhydrogenase in normal and malignant breast tissue.</strong> HERSHEY FB.
  475. </p>
  476. <p>
  477. Eur J Clin Invest. 2003 Oct;33(10):875-82. <strong>Activation of p53 signalling in acetylsalicylic
  478. acid-induced apoptosis in OC2 human oral cancer cells.</strong>
  479. Ho CC, Yang XW, Lee TL, Liao PH, Yang SH, Tsai CH, Chou MY.
  480. </p>
  481. <p>
  482. Cancer. 1959 Jan-Feb;12(1):135-8<strong>. Studies on estrogen-sensitive transhydrogenase: the effect of
  483. estradiol-17 beta on alpha-ketoglutarate production in noncancerous and cancerous human breast
  484. tissue.</strong> HOLLANDER VP, SMITH DE, ADAMSON TE.
  485. </p>
  486. <p>
  487. Carcinogenesis. 2005 Dec;26(12):2095-104. Epub 2005 Jul 20.<strong>
  488. Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer
  489. prognosis.</strong>
  490. Isidoro A, Casado E, Redondo A, Acebo P, Espinosa E, Alonso AM, Cejas P, Hardisson D, Fresno Vara JA,
  491. Belda-Iniesta C, Gonz"lez-Bar"n M, Cuezva JM.
  492. </p>
  493. <p>
  494. Cancer. 1959 Jan-Feb;12(1):127-34. <strong>The assay of estradiol-sensitive transhydrogenase.</strong>
  495. JONAS H, HOLLANDER V.
  496. </p>
  497. <p>
  498. Nat Cell Biol. 2008 May;10(5):611-8. <strong>p53 regulates glucose metabolism through an IKK-NF-kappaB
  499. pathway and inhibits cell transformation.</strong>
  500. Kawauchi K, Araki K, Tobiume K, Tanaka N. "Cancer cells use aerobic glycolysis preferentially for energy
  501. provision and this metabolic change is important for tumour growth. Here, we have found <strong>a link
  502. between the tumour suppressor p53, the transcription factor NF-kappaB and glycolysis."
  503. </strong>
  504. "Taken together, <strong>these data indicate that p53 restricts activation of the IKK-NF-kappaB pathway
  505. through suppression of glycolysis.</strong>
  506. These results suggest that a positive-feedback loop exists, whereby glycolysis drives IKK-NF-kappaB
  507. activation, and that hyperactivation of this loop by loss of p53 is important in oncogene-induced cell
  508. transformation."
  509. </p>
  510. <p>
  511. Eur J Clin Nutr. 2003 Dec;57 Suppl 2:S69-74. <strong>Effects of changes in hydration on protein, glucose and
  512. lipid metabolism in man: impact on health.</strong>
  513. Keller U, Szinnai G, Bilz S, Berneis K.
  514. </p>
  515. <p>
  516. Surg Today. 2001;31(10):853-9. <strong>Serial measurement of arterial lactate concentrations as a prognostic
  517. indicator in relation to the incidence of disseminated intravascular coagulation in patients with
  518. systemic inflammatory response syndrome.</strong> Kobayashi S, Gando S, Morimoto Y, Nanzaki S, Kemmotsu
  519. O.
  520. </p>
  521. <p>
  522. FASEB J. 2005 Jun;19(8):1030-2. <strong>p53 is a suppressor of inflammatory response in mice.</strong>
  523. Komarova EA, Krivokrysenko V, Wang K, Neznanov N, Chernov MV, Komarov PG, Brennan ML, Golovkina TV, Rokhlin
  524. OW, Kuprash DV, Nedospasov SA, Hazen SL, Feinstein E, Gudkov AV.
  525. </p>
  526. <p>
  527. Gen Pharmacol. 1994 Oct;25(6):1257-62. <strong>Serotonin-induced decrease in brain ATP, stimulation of brain
  528. anaerobic glycolysis and elevation of plasma hemoglobin; the protective action of calmodulin
  529. antagonists.</strong>
  530. Koren-Schwartzer N, Chen-Zion M, Ben-Porat H, Beitner R.
  531. </p>
  532. <p>
  533. Agressologie. 1973;14(1):25-30.<strong> [Aspirin, catecholamines and blood lactic acid] </strong>
  534. Laborit G, Baron C, Laborit H.
  535. </p>
  536. <p>
  537. Int J Cancer. 2008 Jun 1;122(11):2422-8.<strong>
  538. Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer.</strong>
  539. Langbein S, Frederiks WM, zur Hausen A, Popa J, Lehmann J, Weiss C, Alken P, Coy JF.
  540. </p>
  541. <p>
  542. Biochemistry (Mosc). 2000 Feb;65(2):223-9. <strong>Bioenergetic response of isolated nerve terminals of rat
  543. brain to osmotic swelling.</strong> Levko AV, Rakovich AA, Konev SV
  544. </p>
  545. <p>
  546. Intensive Care Med. 2003 Feb;29(2):292-300. Epub 2003 Jan 14. <strong>Effects of epinephrine and
  547. norepinephrine on hemodynamics, oxidative metabolism, and organ energetics in endotoxemic rats.</strong>
  548. Levy B, Mansart A, Bollaert PE, Franck P, Mallie JP.
  549. </p>
  550. <p>
  551. Cancer Res. 2007 Oct 1;67(19):9013-7. <strong>Loss of the mitochondrial bioenergetic capacity underlies the
  552. glucose avidity of carcinomas.</strong> L"pez-R"os F, S"nchez-Arag" M, Garc"a-Garc"a E, Ortega AD,
  553. Berrendero JR, Pozo-Rodr"guez F, L"pez-Encuentra A, Ballest"n C, Cuezva JM
  554. </p>
  555. <p>
  556. J Biol Chem. 2002 Jun 28;277(26):23111-5. Epub 2002 Apr 9. <strong>Hypoxia-inducible factor 1 activation by
  557. aerobic glycolysis implicates the Warburg effect in carcinogenesis.</strong> Lu H, Forbes RA, Verma A.
  558. </p>
  559. <p>
  560. Nutr Metab. 1976;20(1):41-61.<strong>
  561. Biotin status and lipid metabolism in adult obese hypercholesterolemic inbred rats.</strong> Marshall
  562. MW, Haubrich M, Washington VA, Chang MW, Young CW, Wheeler MA.
  563. </p>
  564. <p>
  565. J Cardiothorac Vasc Anesth. 2002 Aug;16(4):441-6. <strong>A prospective, randomized comparison of
  566. thromboelastographic coagulation profile in patients receiving lactated Ringer's solution, 6% hetastarch
  567. in a balanced-saline vehicle, or 6% hetastarch in saline during major surgery.</strong> Martin G,
  568. Bennett-Guerrero E, Wakeling H, Mythen MG, el-Moalem H, Robertson K, Kucmeroski D, Gan TJ.
  569. </p>
  570. <p>
  571. J Biol Chem. 2008 Jun 9. [Epub ahead of print] <strong>Pyruvate dehydrogenase complex activity controls
  572. metabolic and malignant phenotype in cancer cells.</strong> McFate T, Mohyeldin A, Lu H, Thakar J,
  573. Henriques J, Halim ND, Wu H, Schell MJ, Tsang TM, Teahan O, Zhou S, Califano JA, Jeoung NH, Harris RA, Verma
  574. A.
  575. </p>
  576. <p>
  577. Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1615-21. <strong>Lactate treatment causes NF-kappaB activation and
  578. CD44 shedding in cultured trabecular meshwork cells.</strong> Miller AM, Nolan MJ, Choi J, Koga T, Shen
  579. X, Yue BY, Knepper PA. "To challenge human trabecular meshwork (TM) cells using lactate to mimic cell stress
  580. and observe the effects on cell viability, NF-kappaB, and membrane type 1 matrix metalloproteinase (MT1-MMP)
  581. expression and the ectodomain shedding of soluble (s)CD44." "Lactate treatment resulted in dose- and
  582. time-dependent effects on human TM cell viability, translocation of NF-kappaB, and activation of MT1-MMP.
  583. <strong>
  584. Increased shedding of sCD44 occurred with the l mM dose of lactate."</strong>
  585. </p>
  586. <p>
  587. Eur J Pharmacol. 2008 Apr 12. [Epub ahead of print]<strong>
  588. Trehalose: A biophysics approach to modulate the inflammatory response during endotoxic shock.</strong>
  589. Minutoli L, Altavilla D, Bitto A, Polito F, Bellocco E, Lagan" G, Fiumara T, Magaz" S, Migliardo F, Venuti
  590. FS, Squadrito F.
  591. </p>
  592. <p>
  593. Acta Neuropathol. 1985;68(2):160-3.<strong>
  594. Blood-brain barrier impairment by low pH buffer perfusion via the internal carotid artery in
  595. rat.</strong>
  596. Nagy Z, Szab" M, H"ttner I.
  597. </p>
  598. <p>
  599. Am J Physiol Endocrinol Metab. 2005 Oct;289(4):E534-42. <strong>Sodium lactate increases LPS-stimulated MMP
  600. and cytokine expression in U937 histiocytes by enhancing AP-1 and NF-kappaB transcriptional
  601. activities.</strong> Nareika A, He L, Game BA, Slate EH, Sanders JJ, London SD, Lopes-Virella MF, Huang
  602. Y.
  603. </p>
  604. <p>
  605. Eukaryot Cell. 2003 Feb;2(1):143-9.<strong>
  606. Glucose regulation of Saccharomyces cerevisiae cell cycle genes.</strong> Newcomb LL, Diderich JA,
  607. Slattery MG, Heideman W. <strong>"These results indicate a link between the rate of glycolysis and the
  608. expression of genes that are critical for passage through G(1).</strong>"
  609. </p>
  610. <p>
  611. J Neuropathol Exp Neurol. 1987 Mar;46(2):154-66.<strong>
  612. Effects of lactic acid on astrocytes in primary culture.</strong> Norenberg MD, Mozes LW, Gregorios JB,
  613. Norenberg LO.
  614. </p>
  615. <p>
  616. Int J Gynecol Pathol. 1997 Jan;16(1):45-51. <strong>Expression of fatty acid synthase is closely linked to
  617. proliferation and stromal decidualization in cycling endometrium.</strong> Pizer ES, Kurman RJ,
  618. Pasternack GR, Kuhajda FP.
  619. </p>
  620. <p>
  621. J Leukoc Biol. 2003 Apr;73(4):482-92. Peritoneal dialysis solutions <strong>
  622. inhibit the differentiation and maturation of human monocyte-derived dendritic cells: effect of lactate
  623. and glucose-degradation products.</strong>
  624. Puig-Kr"ger A, Pello OM, Selgas R, Criado G, Bajo MA, S"nchez-Tomero JA, Alvarez V, del Peso G,
  625. S"nchez-Mateos P, Holmes C, Faict D, L"pez-Cabrera M, Madrenas J, Corb" AL.
  626. </p>
  627. <p>
  628. Cell Biol Int. 2006 Feb;30(2):164-8. Epub 2006 Jan 4. <strong>Influence of estradiol on mammary tumor
  629. collagen solubility in DMBA-induced rat mammary tumors.</strong>
  630. Rajkumar L, Balasubramanian K, Arunakaran J, Govindarajulu P, Srinivasan N.
  631. </p>
  632. <p>
  633. Mol Cell Biol. 2006 Jul;26(14):5449-69.<strong>
  634. Cyclin D1 determines mitochondrial function in vivo.</strong> Sakamaki T, Casimiro MC, Ju X, Quong AA,
  635. Katiyar S, Liu M, Jiao X, Li A, Zhang X, Lu Y, Wang C, Byers S, Nicholson R, Link T, Shemluck M, Yang J,
  636. Fricke ST, Novikoff PM, Papanikolaou A, Arnold A, Albanese C, Pestell R.
  637. </p>
  638. <p>
  639. Cancer Res. 1987 Feb 15;47(4):1065-8.<strong>
  640. Blood nutrient concentrations and tumor growth in vivo in rats: relationships during the onset of an
  641. acute fast.</strong> Sauer LA, Dauchy RT.
  642. </p>
  643. <p>
  644. Ric Clin Lab. 1981;11 Suppl 1:13-33.<strong>
  645. Blood rheology and physiology of microcirculation.</strong> Schmid-Sch"nbein H.
  646. </p>
  647. <p>
  648. Neurochem Int. 2006 Nov;49(6):610-8. Epub 2006 Jun 22. <strong>Characterization of the pro-inflammatory
  649. signaling induced by protein acetylation in microglia.</strong>
  650. Suuronen T, Huuskonen J, Nuutinen T, Salminen A.
  651. </p>
  652. <p>
  653. Am J Vet Res. 1994 Feb;55(2):278-87.<strong>
  654. Clinical and clinicopathologic changes in cows with endotoxin-induced mastitis treated with small
  655. volumes of isotonic or hypertonic sodium chloride administered intravenously.</strong>
  656. Tyler JW, Welles EG, Erskine RJ, Lin HC, Williams MA, Spano JS, Gaslin JT, McClure KA.
  657. </p>
  658. <p>
  659. Brain Res. 2005 Dec 14;1065(1-2):86-91. Epub 2005 Nov 23. <strong>Enhancement of lactate metabolism in the
  660. basolateral amygdala by physical and psychological stress: role of benzodiazepine receptors.
  661. </strong>
  662. Uehara T, Sumiyoshi T, Matsuoka T, Tanaka K, Tsunoda M, Itoh H, Kurachi M.
  663. </p>
  664. <p>
  665. Pharmacol Biochem Behav. 2008 Aug;90(2):273-81. <strong>Lactate production and neurotransmitters; evidence
  666. from microdialysis studies.</strong> Uehara T, Sumiyoshi T, Itoh H, Kurata K.
  667. </p>
  668. <p>
  669. J Natl Cancer Inst. 1968 Aug;41(2):267-86. <strong>Factors affecting anaerobic glycolysis in mouse and rat
  670. liver and in Morris rat hepatomas.</strong> Woods M, Burk D, Hunter J.
  671. </p>
  672. <p>
  673. Exp Neurol. 2004 Mar;186(1):70-7.<strong>
  674. Lactate induced excitotoxicity in hippocampal slice cultures.</strong> Xiang Z, Yuan M, Hassen GW,
  675. Gampel M, Bergold PJ.
  676. </p>
  677. <p>
  678. Masui. 2006 Jun;55(6):699-703. <strong>[Blood lactate concentrations as predictors of outcome in serious
  679. hemorrhagic shock patients] [Article in Japanese]
  680. </strong>
  681. Yamazaki Y, Saito A, Hasegawa K, Takahashi H.
  682. </p>
  683. <p>
  684. Cytokine. 1993 Sep;5(5):436-47. <strong>Cachectin/TNF-mediated lactate production in cultured myocytes is
  685. linked to activation of a futile substrate cycle.</strong>
  686. Zentella A, Manogue K, Cerami A.
  687. </p>
  688. <p>
  689. Chin Med J (Engl). 2002 Jul;115(7):1035-8.<strong>Effect of emodin on proliferation and differentiation of
  690. 3T3-L1 preadipocyte and FAS activity.
  691. </strong>
  692. Zhang C, Teng L, Shi Y, Jin J, Xue Y, Shang K, Gu J.
  693. </p>
  694. © Ray Peat Ph.D. 2009. All Rights Reserved. www.RayPeat.com
  695. </body>
  696. </html>